Quince Therapeutics, Inc. (QNCX) › Net IncomeQuince Therapeutics, Inc. (QNCX) — Net IncomeAnnual figures by fiscal year, from SEC filings.2018: -$12.48M2019: -$36.98M2020: -$76.85M2021: -$89.94M2022: -$51.66M2023: -$31.39M2024: -$56.83M2025: -$83.98M-$83.98M2018Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$83.98M-47.8%2024-$56.83M-81.1%2023-$31.39M+39.2%2022-$51.66M+42.6%2021-$89.94M-17.0%2020-$76.85M-107.8%2019-$36.98M-196.4%2018-$12.48M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share